Read + Share
Koch MW, Camara-Lemarroy C, Strijbis E, Mostert J, et al. Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design
Considerations for Phase 2 Clinical Trials in Progressive MS. Mult Scler 2024;30.
PMID: 39245930
|
 |
|
Koch MW, Camara-Lemarroy C, Strijbis E, Mostert J, et al. Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design
Considerations for Phase 2 Clinical Trials in Progressive MS. Mult Scler 2024;30.
PMID: 39245930
|
|
|
|